📣 VC round data is live. Check it out!
- Public Comps
- Green Cross Health
Green Cross Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Green Cross Health and similar public comparables like MARX Biotech, Profarma, BlueMTec, d1000 and more.
Green Cross Health Overview
About Green Cross Health
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. Its pharmacy services segment includes operations like providing pharmacy services through consolidated stores, equity-accounted investments, and franchise stores. The medical service segment provides complete family healthcare services through general practitioners, accident, and medical centers.
Founded
1981
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$195M
Valuation Multiples
Start free trialGreen Cross Health Financials
Green Cross Health reported last fiscal year revenue of $312M and EBITDA of $30M.
In the same fiscal year, Green Cross Health generated $179M in gross profit, $30M in EBITDA, and $10M in net income.
Revenue (LTM)
Green Cross Health P&L
In the most recent fiscal year, Green Cross Health reported revenue of $312M and EBITDA of $30M.
Green Cross Health is profitable as of last fiscal year, with gross margin of 57%, EBITDA margin of 10%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Green Cross Health Stock Performance
Green Cross Health has current market cap of $128M, and enterprise value of $195M.
Market Cap Evolution
Green Cross Health's stock price is $0.89.
Green Cross Health share price increased by 9.5% in the last 30 days, and by 90.9% in the last year.
Green Cross Health has an EPS (earnings per share) of $0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $195M | $128M | 0.9% | 9.5% | 24.8% | 90.9% | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGreen Cross Health Valuation Multiples
Green Cross Health trades at 0.6x EV/Revenue multiple, and 6.5x EV/EBITDA.
EV / Revenue (LTM)
Green Cross Health Financial Valuation Multiples
As of May 13, 2026, Green Cross Health has market cap of $128M and EV of $195M.
Green Cross Health has a P/E ratio of 13.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Green Cross Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Green Cross Health Margins & Growth Rates
In the most recent fiscal year, Green Cross Health reported gross margin of 57%, EBITDA margin of 10%, and net margin of 3%.
Green Cross Health Margins
Green Cross Health Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Green Cross Health Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Green Cross Health Competitors
Green Cross Health competitors include MARX Biotech, Profarma, BlueMTec, d1000, Fangzhou, Talea Group, PetMeds, SC Ropharma, Farmacosmo and Rise.
Most Green Cross Health public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.4x | — | 37.5x | — | |||
| 0.2x | — | 3.9x | — | |||
| 0.7x | — | 101.9x | — | |||
| 0.3x | — | 3.8x | — | |||
| 0.3x | 0.3x | 31.3x | 26.2x | |||
| 0.6x | — | 24.4x | — | |||
| 0.1x | 0.1x | 3.2x | (0.6x) | |||
| 0.2x | — | 4.4x | — | |||
This data is available for Pro users. Sign up to see all Green Cross Health competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Green Cross Health
| When was Green Cross Health founded? | Green Cross Health was founded in 1981. |
| Where is Green Cross Health headquartered? | Green Cross Health is headquartered in New Zealand. |
| Is Green Cross Health publicly listed? | Yes, Green Cross Health is a public company listed on New Zealand Exchange. |
| What is the stock symbol of Green Cross Health? | Green Cross Health trades under GXH ticker. |
| When did Green Cross Health go public? | Green Cross Health went public in 2000. |
| Who are competitors of Green Cross Health? | Green Cross Health main competitors include MARX Biotech, Profarma, BlueMTec, d1000, Fangzhou, Talea Group, PetMeds, SC Ropharma, Farmacosmo, Rise. |
| What is the current market cap of Green Cross Health? | Green Cross Health's current market cap is $128M. |
| What is the current revenue of Green Cross Health? | Green Cross Health's last fiscal year revenue is $312M. |
| What is the current EV/Revenue multiple of Green Cross Health? | Current revenue multiple of Green Cross Health is 0.6x. |
| Is Green Cross Health profitable? | No, Green Cross Health is not profitable. |
| How many companies Green Cross Health has acquired to date? | Green Cross Health hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Green Cross Health has invested to date? | Green Cross Health hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Green Cross Health
Lists including Green Cross Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.